Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.24%
#3 Glidr Glidr +36.87%
#4 CoW Protocol CoW Protocol +33.98%
#5 Humanity Humanity +28.27%
#6 Codatta Codatta +19.36%
#7 Walrus Walrus +17.42%
#8 Enso Enso +17.35%
#9 The Black Bull The Black Bull +14.68%
#10 Collector Crypt Collector Crypt +14.46%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Hybrigenics S.A. Hybrigenics S.A.

Hybrigenics S.A.

ALHYG
Rank in Stocks #36421
Hybrigenics SA is a biotechnology firm, along with its subsidiaries,... Hybrigenics SA is a biotechnology firm, along with its subsidiaries, headquartered in Gallargues-le-Montueux, France. The company specializes in pioneering biotechnological advancements, particularly within oncology, regenerative medicine, and anti-aging therapies. Additionally, Hybrigenics is actively involved in developing technical solutions that leverage adipose tissue cells and stem cells. It operates as a subsidiary of Diagnostic Medical Systems S.A.
Share Price
$0.01155578
Last synced: 2024-07-16
Market Cap
$2.70M
Change (1 day)
2.98%
Change (1 year)
0.00%
Country
FR
Trade Hybrigenics S.A. (ALHYG)

Category

Healthcare
Revenue for Hybrigenics S.A. (ALHYG)
Revenue in Dec 2023 TTM: $424.28K
According to Hybrigenics S.A. latest financial reports the company's current revenue (TTM) is $424.28K. In 2022 the company made a revenue of $1.67K a decrease compared to the revenue in the year 2021 that was $167.31K. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Hybrigenics S.A. from 2009 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $424.28K 0.00%
2023 $424.28K 25,254.72%
2022 $1.67K -99.00%
2021 $167.31K -8.79%
2020 $183.44K -30.41%
2019 $263.58K 198.93%
2018 $88.18K -96.09%
2017 $2.26M -40.55%
2016 $3.79M -24.61%
2015 $5.03M -25.04%
2014 $6.71M -13.16%
2013 $7.73M 28.05%
2012 $6.04M 106.82%
2011 $2.92M -41.54%
2010 $4.99M -16.46%
2009 $5.98M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 2,975,379.11%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 1,419,084.80%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 2,382,957.64%
BE